CNADF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Apr 10 closing price
Capitalization
3.98M
ZTS
Price
$143.50
Change
+$2.37 (+1.68%)
Updated
Sep 26 closing price
Capitalization
63.6B
37 days until earnings call
Interact to see
Advertisement

CNADF vs ZTS

Header iconCNADF vs ZTS Comparison
Open Charts CNADF vs ZTSBanner chart's image
CANADABIS CAP
Price$0.06
Change-$0.00 (-0.00%)
Volume$6K
Capitalization3.98M
ZOETIS
Price$143.50
Change+$2.37 (+1.68%)
Volume$2.58M
Capitalization63.6B
CNADF vs ZTS Comparison Chart in %
Loading...
CNADF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNADF vs. ZTS commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNADF is a Hold and ZTS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (CNADF: $0.06 vs. ZTS: $143.50)
Brand notoriety: CNADF: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CNADF: 100% vs. ZTS: 85%
Market capitalization -- CNADF: $3.98M vs. ZTS: $63.6B
CNADF [@Pharmaceuticals: Generic] is valued at $3.98M. ZTS’s [@Pharmaceuticals: Generic] market capitalization is $63.6B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNADF’s FA Score shows that 1 FA rating(s) are green whileZTS’s FA Score has 2 green FA rating(s).

  • CNADF’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 2 green, 3 red.
According to our system of comparison, ZTS is a better buy in the long-term than CNADF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNADF’s TA Score shows that 1 TA indicator(s) are bullish while ZTS’s TA Score has 4 bullish TA indicator(s).

  • CNADF’s TA Score: 1 bullish, 0 bearish.
  • ZTS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CNADF is a better buy in the short-term than ZTS.

Price Growth

CNADF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while ZTS (@Pharmaceuticals: Generic) price change was -1.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

ZTS is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($63.6B) has a higher market cap than CNADF($3.98M). ZTS has higher P/E ratio than CNADF: ZTS (24.70) vs CNADF (11.57). CNADF YTD gains are higher at: 78.571 vs. ZTS (-11.065). ZTS has higher annual earnings (EBITDA): 4.02B vs. CNADF (1.54M). ZTS has more cash in the bank: 1.44B vs. CNADF (948K). CNADF has less debt than ZTS: CNADF (9.18M) vs ZTS (6.79B). ZTS has higher revenues than CNADF: ZTS (9.39B) vs CNADF (17.2M).
CNADFZTSCNADF / ZTS
Capitalization3.98M63.6B0%
EBITDA1.54M4.02B0%
Gain YTD78.571-11.065-710%
P/E Ratio11.5724.7047%
Revenue17.2M9.39B0%
Total Cash948K1.44B0%
Total Debt9.18M6.79B0%
FUNDAMENTALS RATINGS
ZTS: Fundamental Ratings
ZTS
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
19
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNADFZTS
RSI
ODDS (%)
Bullish Trend 3 days ago
40%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
60%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
66%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
59%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
29%
Bearish Trend 3 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
33%
Bearish Trend 3 days ago
59%
Advances
ODDS (%)
N/A
Bullish Trend 24 days ago
57%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
57%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
67%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
CNADF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MICFF5.23N/A
N/A
Mint Income Fund
QVMS27.90N/A
N/A
Invesco S&P SmallCp 600 QVM Mlt-fctr ETF
PCRB49.30-0.01
-0.01%
Putnam ESG Core Bond ETF
VTEB49.98-0.03
-0.06%
Vanguard Tax-Exempt Bond ETF
MSOX6.06-0.34
-5.31%
AdvisorShares MSOS Daily Leveraged ETF

CNADF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNADF has been loosely correlated with CHSYF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CNADF jumps, then CHSYF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNADF
1D Price
Change %
CNADF100%
N/A
CHSYF - CNADF
38%
Loosely correlated
N/A
ZTS - CNADF
24%
Poorly correlated
+1.68%
CPHI - CNADF
20%
Poorly correlated
-3.90%
ESAIY - CNADF
5%
Poorly correlated
-0.23%
HLNCF - CNADF
4%
Poorly correlated
-3.57%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with VTRS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+1.68%
VTRS - ZTS
48%
Loosely correlated
+0.32%
ELAN - ZTS
47%
Loosely correlated
+3.65%
PAHC - ZTS
41%
Loosely correlated
+2.02%
AMRX - ZTS
38%
Loosely correlated
+1.56%
HLN - ZTS
38%
Loosely correlated
+1.15%
More